- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Abbott Laboratories
+ Add to WatchlistABT:US
36.5900 USD 0.2400 0.65%As of 20:04:03 ET on 05/17/2013.
Snapshot for Abbott Laboratories (ABT)
| Open: | 36.8200 | Day's Range: | 36.2900 - 36.9400 | Volume: | 7,050,721 |
|---|---|---|---|---|---|
| Previous Close: | 36.8300 | 52wk Range: | 28.4500 - 37.7000 | 1-Yr Rtn: | +27.10% |
Key Statistics for ABT
| Current P/E Ratio (ttm) | 8.6103 |
|---|---|
| Estimated P/E(12/2013) | 18.1408 |
| Relative P/E vs. SPX | 0.5277 |
| Earnings Per Share (USD) (ttm) | 4.2496 |
| Est. EPS (USD) (12/2013) | 2.0170 |
| Est. PEG Ratio | 1.5843 |
| Market Cap (M USD) | 57,038.86 |
| Shares Outstanding (M) | 1,558.87 |
| 30 Day Average Volume | 6,523,388 |
| Price/Book (mrq) | 2.5252 |
| Price/Sale (ttm) | 1.6151 |
| Dividend Indicated Gross Yield | 1.53% |
| Cash Dividend (USD) | 0.1400 |
| Last Dividend | 04/11/2013 |
| 5 Year Dividend Growth | -0.53% |
| Next Earnings Announcement | 07/18/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ABT
Company Profile & Key Executives for ABT
Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company's products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
| Miles D WhiteChairman/CEO | Thomas C FreymanExec VP:Finance/CFO |
| John M CapekExec VP:Medical Devices | Richard W AshleyExec VP:Corp Development |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ABT News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page